Cigna Healthcare (Commercial) · basivertebral nerve ablation
v1verified 2026-07-24manual-pull source
✗ investigational / not covered · commercial
Criteria checklist
0 of 5 tickedIndications
- enumerated: yes
- covered:
- investigational:
- radiofrequency ablation of the intraosseous basivertebral nerve for vertebrogenic back pain — experimental, investigational, or unproven (EIU)
Conservative care
- required: not stated in the policy
- note: n/a — not covered
Trial
- required: no
- min duration days: not stated in the policy
- success criteria: not stated in the policy
- threshold is binding: no
Psychological evaluation
- required: no
- must clear: no
- note posture: n/a
Quantity limits
- applies: no
Payor-specific notes
Cigna (eviCore CMM-208) deems basivertebral nerve ablation EIU (experimental/investigational/ unproven). DIVERGES from Medicare (LCD/R&N coverage) and Anthem (Carelon coverage); aligns with UHC (also investigational). From the actual fetched eviCore PDF.
Ticks are a documentation aid — nothing is stored; they reset on reload.
Dot phrase
Cigna (eviCore CMM-208) deems basivertebral nerve ablation **experimental/investigational/unproven**. No medical-necessity pathway.
.INTRACEPTCIGNA
This patient is a candidate for basivertebral nerve ablation, but BVNA is not a covered benefit under this plan: Cigna (eviCore CMM-208) deems it experimental, investigational, and unproven, and there is no medical-necessity pathway. My clinical rationale is documented here: *** . Alternatives have been discussed with the patient. Any appeal must contest the EIU determination itself rather than argue medical necessity.
Cautions
Prior-auth pathway
- required: not stated in the policy
- note: n/a — denied as EIU
Provenance
- authority:
- type: commercial_policy
- id: Cigna eviCore CMM-208
- title: Ablations/Denervations of Facet Joints and Peripheral Nerves (CMM-208)
- delegated by: Cigna (authored by eviCore / Evernorth)
- applies because: Cigna's eviCore ablation guideline addresses basivertebral nerve ablation
- source: https://www.evicore.com/sites/default/files/clinical-guidelines/2025-09/Cigna_CMM-208%20Ablations%20Denerv%20of%20Facet%20Joints%20&%20Peripheral%20Nerves_Final_V2.0.2025_Eff12.18.2025_Pub09.17.2025_1.pdf
- archived copy:
sources/evicore_cmm208-ablations-bvna_2025-12-18.pdf(sha256 3c61d665147b… — kept in the content repo, not served here) - effective: 2025-12-18 · payor last reviewed: 2025-12-18 · we verified: 2026-07-24 · v1
Change history
- 2026-07-24commercial cells: re-verify 27 source PDFs by SHA-256 (Carelon/eviCore/UHC/Cigna) - all unchanged vs committed archive; last_verified -> 2026-07-24
3615c231f0 - 2026-06-30Archive commercial source PDFs into sources/ + wire source_file/source_hash
c5466694c8 - 2026-06-29Add commercial Intracept (BVNA) cells: Anthem, UHC, Cigna
6602e687a8